E. Quoix (Strasbourg, France), A. Meert (Brussels, Belgium)
Telomerase expression in lung tumors
S. A. Lantuejoul, S. Jean Charles, M. Luc, B. Christian, B. Elisabeth (Grenoble, Fontenay aux Roses, France)
|  |
Correlation of p53, EGFR and HER2 expression in the diagnostic biopsies and the corresponding resected tumours in NSCLC
A. P. Meert, B. Martin, J. M. Verdebout, T. Bosschaerts, M. Paesmans, V. Ninane, J. P. Sculier (Brussels, Belgium)
| |
Nuclear expression of Y-Box binding protein (YB-1) as a negative prognostic marker in non-small cell lung cancer
C. Gessner, U. Liebers, C. Woischwill, P. Stiehl, C. Witt, H. D. Royer, G. Wolff (Leipzig, Berlin, Germany)
|  |
Recoverin as a paraneoplastic antigen in lung cancer
M. S. Savchenko, A. V. Bazhin, O. N. Shifrina, S. Y. Chikina, S. A. Demoura, E. A. Kogan, A. G. Chuchalin, P. P. Philippov (Moscow, Russia)
| |
Elevated endogenous thrombin potential in patients with lung cancer
H. J. Seyfarth, A. Siegemund, T. Siegemund, T. Geike, S. Hammerschmidt, J. Schauer, H. Wirtz (Leipzig, Germany)
| |
Inhibition of tumor growth and metastatic lung tumors in mice by adenovirus-mediated interferon-β gene therapy
R. Wiewrodt, M. Odaka, P. DeLong, V. Kapoor, L. R. Kaiser, S. M. Albelda (Mainz, Germany; Philadelphia, United States Of America)
| |
The role of CD40 molecule in human lung cancer and its application in immunotherapy
J. A. Huang, T. L. Wang, Y. M. Zhuang, Y. B. Zhu, T. Gu, X. G. Zhang (Suzhou, China)
| |
Induction of enhanced antitumor immunity by fusion of Interleukin-12 gene-modified cancer cells with dendritic cells
T. Suzuki, T. Fukuhara, M. Tanaka, R. Tazawa, Y. Saijo, T. Nukiwa (Sendai, Japan)
| |